PDB0106 Optimizing the management of patients with virologic non-suppressionPoster exhibitionB5
PDB0202 Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysisPoster exhibitionB24
PDB0203 Task-shared, nurse-delivered, cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV clinics in Kayelitsha, South Africa: A randomized controlled trialPoster exhibitionB16
PDB0204 High burden of depression among clients initiating same-day antiretroviral therapy at the Anonymous Clinic, Bangkok ThailandPoster exhibitionB16
PDB0205 Longitudinal study of neurocognitive disorders and associated structural brain changes in adolescent HIVPoster exhibitionB56
PDB0206 Assessing neurocognitive functioning among adolescents and young adults with perinatally acquired HIV in Thailand: Support for the NeuroScreen appPoster exhibitionB8
PDB0302 Incidence and risk factors for STIs among MSM on PrEP - A post-hoc analysis of the ANRS IPERGAY trialPoster exhibitionB14
PDB0303 Persistently high rates of sexually transmitted infections in the DISCOVER HIV PrEP trialPoster exhibitionB14
PDB0304 Pooled pharyngeal, rectal and urine samples for the Point-of-Care detection of Chlamydia trachomatis and Neisseria gonorrhoeae by lay-providers in Key Population-Led Health Services in ThailandPoster exhibitionB8
PDB0305 Cytomegalovirus retinitis in advanced HIV patients: Screening and care in MozambiquePoster exhibitionB11
seek-warrow-warrow-eseek-e21 - 30 of 2297 items